Old Web
English
Sign In
Acemap
>
authorDetail
>
Kanta Horie
Kanta Horie
Psychology
Phosphodiesterase
Diabetes mellitus
Psychiatry
Endocrinology
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PHASE 1 MULTIPLE ASCENDING DOSE (MAD) STUDY OF PHOSPHODIESTERASE-9 INHIBITOR E2027: CONFIRMATION OF TARGET ENGAGEMENT AND SELECTION OF PHASE 2 DOSE IN DEMENTIA WITH LEWY BODIES
2018
Alzheimers & Dementia
Ishani Landry
Robert Lai
Peter Boyd
Jagadeesh Aluri
Min-Kun Chang
Mitsuhiro Ino
Kanta Horie
Edgar Schuck
Johan Luthman
Show All
Source
Cite
Save
Citations (1)
EFFECT OF REPEATED ADMINISTRATION OF E2027, A NOVEL PHOSPHODIESTERASE-9 INHIBITOR, ON CYCLIC GMP LEVELS IN RAT CEREBROSPINAL FLUID
2018
Alzheimers & Dementia
Mai Ando
Yukio Ishikawa
Kanta Horie
Toshiki Mochizuki
Masae Yamamoto
Naoto Watanabe
Yosuke Nakatani
Sadaharu Kotani
Tatsuto Fukushima
Show All
Source
Cite
Save
Citations (0)
PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR
2017
Alzheimers & Dementia
Robert Lai
Robert Gordon
Min-Kun Chang
Peter Boyd
Ishani Savant-Landry
Jagadeesh Aluri
Mitsuhiro Ino
Kanta Horie
Sadaharu Kotani
Edgar Schuck
Johan Luthman
Show All
Source
Cite
Save
Citations (0)
1